165 related articles for article (PubMed ID: 19184617)
1. Pulmonary spray dried powders of tobramycin containing sodium stearate to improve aerosolization efficiency.
Parlati C; Colombo P; Buttini F; Young PM; Adi H; Ammit AJ; Traini D
Pharm Res; 2009 May; 26(5):1084-92. PubMed ID: 19184617
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of sodium stearate on the moisture-induced deterioration of hygroscopic spray-dried powders.
Yu J; Romeo MC; Cavallaro AA; Chan HK
Int J Pharm; 2018 Apr; 541(1-2):11-18. PubMed ID: 29454904
[TBL] [Abstract][Full Text] [Related]
3. Physicochemical characterization and aerosol dispersion performance of organic solution advanced spray-dried microparticulate/nanoparticulate antibiotic dry powders of tobramycin and azithromycin for pulmonary inhalation aerosol delivery.
Li X; Vogt FG; Hayes D; Mansour HM
Eur J Pharm Sci; 2014 Feb; 52():191-205. PubMed ID: 24215736
[TBL] [Abstract][Full Text] [Related]
4. Design, characterization, and aerosol dispersion performance modeling of advanced co-spray dried antibiotics with mannitol as respirable microparticles/nanoparticles for targeted pulmonary delivery as dry powder inhalers.
Li X; Vogt FG; Hayes D; Mansour HM
J Pharm Sci; 2014 Sep; 103(9):2937-2949. PubMed ID: 24740732
[TBL] [Abstract][Full Text] [Related]
5. L-Leucine as an excipient against moisture on in vitro aerosolization performances of highly hygroscopic spray-dried powders.
Li L; Sun S; Parumasivam T; Denman JA; Gengenbach T; Tang P; Mao S; Chan HK
Eur J Pharm Biopharm; 2016 May; 102():132-41. PubMed ID: 26970252
[TBL] [Abstract][Full Text] [Related]
6. Protection of hydrophobic amino acids against moisture-induced deterioration in the aerosolization performance of highly hygroscopic spray-dried powders.
Yu J; Chan HK; Gengenbach T; Denman JA
Eur J Pharm Biopharm; 2017 Oct; 119():224-234. PubMed ID: 28655664
[TBL] [Abstract][Full Text] [Related]
7. Improved Aerosolization Stability of Inhalable Tobramycin Powder Formulation by Co-Spray Drying with Colistin.
Pathak V; Park H; Zemlyanov D; Bhujbal SV; Ahmed MU; Azad MAK; Li J; Zhou QT
Pharm Res; 2022 Nov; 39(11):2781-2799. PubMed ID: 35915320
[TBL] [Abstract][Full Text] [Related]
8. Development of excipients free inhalable co-spray-dried tobramycin and diclofenac formulations for cystic fibrosis using two and three fluid nozzles.
Marasini N; Sheikh Z; Wong CYJ; Hosseini M; Spicer PT; Young P; Xin Ong H; Traini D
Int J Pharm; 2022 Aug; 624():121989. PubMed ID: 35809834
[TBL] [Abstract][Full Text] [Related]
9. Preparation and characterization of spray-dried tobramycin powders containing nanoparticles for pulmonary delivery.
Pilcer G; Vanderbist F; Amighi K
Int J Pharm; 2009 Jan; 365(1-2):162-9. PubMed ID: 18782609
[TBL] [Abstract][Full Text] [Related]
10. Spray-dried carrier-free dry powder tobramycin formulations with improved dispersion properties.
Pilcer G; Vanderbist F; Amighi K
J Pharm Sci; 2009 Apr; 98(4):1463-75. PubMed ID: 18752304
[TBL] [Abstract][Full Text] [Related]
11. Characterization of excipient enhanced growth (EEG) tobramycin dry powder aerosol formulations.
Hassan A; Farkas D; Longest W; Hindle M
Int J Pharm; 2020 Dec; 591():120027. PubMed ID: 33130220
[TBL] [Abstract][Full Text] [Related]
12. The influence of storage relative humidity on aerosolization of co-spray dried powders of hygroscopic kanamycin with the hydrophobic drug rifampicin.
Momin MAM; Tucker IG; Das SC
Drug Dev Ind Pharm; 2019 Jul; 45(7):1205-1213. PubMed ID: 30990097
[TBL] [Abstract][Full Text] [Related]
13. Carrier-free combination for dry powder inhalation of antibiotics in the treatment of lung infections in cystic fibrosis.
Pilcer G; De Bueger V; Traina K; Traore H; Sebti T; Vanderbist F; Amighi K
Int J Pharm; 2013 Jul; 451(1-2):112-20. PubMed ID: 23643509
[TBL] [Abstract][Full Text] [Related]
14. Synergistic antibacterial effect of inhaled aztreonam and tobramycin fixed dose combination to combat multidrug-resistant Gram-negative bacteria.
Wang J; Kutter JP; Mu H; Moodley A; Yang M
Int J Pharm; 2020 Nov; 590():119877. PubMed ID: 32927003
[TBL] [Abstract][Full Text] [Related]
15. Dry powder inhalers of gentamicin and leucine: formulation parameters, aerosol performance and in vitro toxicity on CuFi1 cells.
Aquino RP; Prota L; Auriemma G; Santoro A; Mencherini T; Colombo G; Russo P
Int J Pharm; 2012 Apr; 426(1-2):100-107. PubMed ID: 22301426
[TBL] [Abstract][Full Text] [Related]
16. Investigations on the Mechanism of Magnesium Stearate to Modify Aerosol Performance in Dry Powder Inhaled Formulations.
Jetzer MW; Schneider M; Morrical BD; Imanidis G
J Pharm Sci; 2018 Apr; 107(4):984-998. PubMed ID: 29247741
[TBL] [Abstract][Full Text] [Related]
17. Correlations between surface composition and aerosolization of jet-milled dry powder inhaler formulations with pharmaceutical lubricants.
Mangal S; Park H; Nour R; Shetty N; Cavallaro A; Zemlyanov D; Thalberg K; Puri V; Nicholas M; Narang AS; Zhou QT
Int J Pharm; 2019 Sep; 568():118504. PubMed ID: 31299339
[TBL] [Abstract][Full Text] [Related]
18. Effects of Moisture-Induced Crystallization on the Aerosol Performance of Spray Dried Amorphous Ciprofloxacin Powder Formulations.
Shetty N; Zeng L; Mangal S; Nie H; Rowles MR; Guo R; Han Y; Park JH; Zhou QT
Pharm Res; 2018 Jan; 35(1):7. PubMed ID: 29294198
[TBL] [Abstract][Full Text] [Related]
19. Design, characterization, and aerosolization of organic solution advanced spray-dried moxifloxacin and ofloxacin dipalmitoylphosphatidylcholine (DPPC) microparticulate/nanoparticulate powders for pulmonary inhalation aerosol delivery.
Duan J; Vogt FG; Li X; Hayes D; Mansour HM
Int J Nanomedicine; 2013; 8():3489-505. PubMed ID: 24092972
[TBL] [Abstract][Full Text] [Related]
20. Impact of Solid-State Properties on the Aerosolization Performance of Spray-Dried Curcumin Powders.
Zhang Q; Li Y; Li L; Cheng Y; Yu F; Li R; Hou S
AAPS PharmSciTech; 2023 Mar; 24(3):78. PubMed ID: 36918500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]